Signaling Pathways Drive Cisplatin Resistance via SOX2
In the ever-evolving battle against cancer, one of the most formidable challenges continues to be drug resistance, which severely limits ...
In the ever-evolving battle against cancer, one of the most formidable challenges continues to be drug resistance, which severely limits ...
Cancer’s relentless capacity to outmaneuver treatment remains one of the most formidable obstacles in modern medicine. Among the most vexing ...
In a groundbreaking advancement poised to reshape pancreatic cancer therapeutics, researchers at the Massachusetts Institute of Technology (MIT) and the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine